Published Technical Documents
Standards, guidance and application literature from the bodies and manufacturers that publish it. Every entry links to the document page itself and quotes the sentence that says what it covers.
Standards, guidance and application literature from the bodies and manufacturers that publish it. Every entry links to the document page itself and quotes the sentence that says what it covers.
Clinical and Laboratory Standards Institute (CLSI)
CLSI H59 catalogue record. Consult the publisher for the complete standard, edition and applicable requirements.
Fuente: clsi.org · Consultado el 2026-10-19
Clinical and Laboratory Standards Institute (CLSI)
CLSI EP10 catalogue record. Consult the publisher for the complete standard, edition and applicable requirements.
Fuente: clsi.org · Consultado el 2026-10-19
Clinical and Laboratory Standards Institute (CLSI)
CLSI M07 catalogue record. Consult the publisher for the complete standard, edition and applicable requirements.
Fuente: clsi.org · Consultado el 2026-10-19
Clinical and Laboratory Standards Institute (CLSI)
CLSI EP06 catalogue record. Consult the publisher for the complete standard, edition and applicable requirements.
Fuente: clsi.org · Consultado el 2026-10-19
Clinical and Laboratory Standards Institute (CLSI)
CLSI EP09 catalogue record. Consult the publisher for the complete standard, edition and applicable requirements.
Fuente: clsi.org · Consultado el 2026-10-19
U.S. Food and Drug Administration
FDA source page describing its voluntary pilot program for selected oncology drugs used with in vitro diagnostic tests; participation and current status must be checked with FDA.
Fuente: fda.gov · Consultado el 2026-10-19
U.S. Food and Drug Administration
FDA guidance on development and labeling considerations for companion diagnostics intended to support a group of oncology therapeutic products.
Fuente: fda.gov · Consultado el 2026-10-19
U.S. Food and Drug Administration
FDA special controls source document covering RNA specimen collection, stabilization and purification systems for molecular diagnostic RT-PCR.
Fuente: fda.gov · Consultado el 2026-10-19
U.S. Food and Drug Administration
FDA question-and-answer guidance about commercially distributed analyte specific reagents. Consult the original document and current FDA notices for applicable requirements.
Fuente: fda.gov · Consultado el 2026-10-19
U.S. Food and Drug Administration
FDA guidance page for developers of therapeutic products and corresponding in vitro companion diagnostic devices.
Fuente: fda.gov · Consultado el 2026-10-19
U.S. Food and Drug Administration
FDA source document on reporting diagnostic test study results, including the choice of comparison standard and measures of test performance.
Fuente: fda.gov · Consultado el 2026-10-19
Roche Diagnostics
Why structured testing algorithms matter for diagnosing infectious diseases, and how they are built.
Fuente: diagnostics.roche.com · Consultado el 2026-10-30
Every item here is a technical document its publisher made public: a standards-body scope page, a regulator guidance document, or a manufacturer application note or journal article. The entry links to that page and quotes the sentence describing what the document covers. It is not a record of work IVDmap has done.
Target audienceImplementation teams, labs, procurement managers
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-01
2026-10-09
professional use
Every document below is published by the body named on it, and this page links to that page. Nothing here is a record of work IVDmap has done.